TBX4 variants have been reported in childhood-onset PAH patients [28] and might contribute to PAH by decreasing the activation of the BMP/TGF–β/SMAD signaling pathways [29]. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.